Literature DB >> 10582665

Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions.

H Bouterfa1, A R Darlapp, E Klein, T Pietsch, K Roosen, J C Tonn.   

Abstract

Local tumor invasion into the surrounding brain tissue is a major characteristic of malignant gliomas. These processes critically depend on the interaction of tumor cells with various extracellular matrix (ECM) components. Because only little quantitative information about expression of ECM gene products in general and expression in response to alterations of the surrounding environment is available, the present study was designed. Four human glioblastoma cell lines (U373MG, U138MG, U251MG, GaMG) as well as four human melanoma cell lines (MV3, BLM, 530, IF6) were tested with semiquantitative RT-PCR for their ability to express mRNA of different human ECM components (fibronectin, decorin, tenascin, collagen I, collagen IV, versican). In addition, two human medulloblastoma (MHH-Med 1, MHH-Med 4) and two fibrosarcoma (HT1080, U2OS) cell lines were analyzed. Cells which were grown in DMEM medium containing 10% FCS expressed most of the analyzed protein components. When the same medium, but depleted of ECM proteins by filtrating through a membrane with cut-off at > 100 kD was used, basal mRNA expression of the ECM proteins was changed in most of the examined cell lines. Using serum free conditions, most of the cell lines again showed a variation in the expression pattern of mRNA encoding for the different ECM proteins compared to the other medium conditions. Comparing different cell lines from one tumor entity or different tumor groups, ECM expression was heterogeneous with regard to the different tumor entities as well as within the entities themselves. Migration assays revealed heterogeneous responses between the different cell lines, ECM components and culture conditions, making it difficult to correlate ECM expression patterns and migratory behavior. Our results revealed that all examined cell lines are able to produce ECM proteins in vitro. This suggests that tumor cells can modulate their microenvironment in vitro which has to be taken into consideration for studies related to migration and invasion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582665     DOI: 10.1023/a:1006331416283

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  45 in total

1.  ECM dependent and integrin mediated tumor cell migration of human glioma and melanoma cell lines under serum-free conditions.

Authors:  R H Goldbrunner; H K Haugland; C E Klein; S Kerkau; K Roosen; J C Tonn
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

2.  Aggrecan-versican-neurocan family proteoglycans.

Authors:  R U Margolis; R K Margolis
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 3.  Interactions of developing neurons with the extracellular matrix.

Authors:  P C Letourneau; M L Condic; D M Snow
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

4.  Tenascin distribution in human brain tumours.

Authors:  P Castellani; A Dorcaratto; A Siri; L Zardi; G L Viale
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  Expression of decorin in human tissues and cell lines and defined chromosomal assignment of the gene locus (DCN).

Authors:  L Pulkkinen; T Alitalo; T Krusius; L Peltonen
Journal:  Cytogenet Cell Genet       Date:  1992

Review 6.  The role of growth factors in the malignant and invasive progression of intrinsic brain tumours.

Authors:  P E Finn; R Bjerkvig; G J Pilkington
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

7.  Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.

Authors:  M Higuchi; T Ohnishi; N Arita; S Hiraga; T Hayakawa
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Glioblastoma cells do not intravasate into blood vessels.

Authors:  J J Bernstein; C A Woodard
Journal:  Neurosurgery       Date:  1995-01       Impact factor: 4.654

Review 9.  Interactions of glioma cells and extracellular matrix.

Authors:  W Paulus; J C Tonn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Fibronectin has a dual role in locomotion and anchorage of primary chick fibroblasts and can promote entry into the division cycle.

Authors:  J R Couchman; D A Rees; M R Green; C G Smith
Journal:  J Cell Biol       Date:  1982-05       Impact factor: 10.539

View more
  20 in total

1.  RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.

Authors:  Neveen Said; Marta Sanchez-Carbayo; Steven C Smith; Dan Theodorescu
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry.

Authors:  Yuan Tian; Francisco J Esteva; Jin Song; Hui Zhang
Journal:  Mol Cell Proteomics       Date:  2012-02-07       Impact factor: 5.911

Review 3.  Sample preparation strategies for efficient correlation of 3D SIM and soft X-ray tomography data at cryogenic temperatures.

Authors:  Chidinma A Okolo; Ilias Kounatidis; Johannes Groen; Kamal L Nahas; Stefan Balint; Thomas M Fish; Mohamed A Koronfel; Aitziber L Cortajarena; Ian M Dobbie; Eva Pereiro; Maria Harkiolaki
Journal:  Nat Protoc       Date:  2021-05-14       Impact factor: 13.491

4.  uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.

Authors:  Reshu Gupta; Arun Kumar Nalla; Venkateswara Rao Gogineni; Chandramu Chetty; Praveen Bhoopathi; Jeffrey D Klopfenstein; Andrew J Tsung; Sanjeeva Mohanam; Jasti S Rao
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

5.  Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.

Authors:  Qi Wang; Jun Qian; Junyu Wang; Chun Luo; Juxiang Chen; Guohan Hu; Yicheng Lu
Journal:  J Neurooncol       Date:  2013-01-06       Impact factor: 4.130

6.  Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion.

Authors:  Angélica Regina Cappellari; Gabriela Jouglard Vasques; Luci Bavaresco; Elizandra Braganhol; Ana Maria Oliveira Battastini
Journal:  Mol Cell Biochem       Date:  2011-08-21       Impact factor: 3.396

7.  Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer.

Authors:  D Ohlund; C Lundin; B Ardnor; M Oman; P Naredi; M Sund
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

8.  Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas.

Authors:  Matthias W Wagner; W Robert Bell; Jason Kern; Thangamadhan Bosemani; Joyce Mhlanga; Kathryn A Carson; Kenneth J Cohen; Eric H Raabe; Fausto Rodriguez; Thierry A G M Huisman; Andrea Poretti
Journal:  Eur J Radiol       Date:  2016-02-04       Impact factor: 3.528

9.  Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times.

Authors:  C Goetz; P Riva; G Poepperl; F J Gildehaus; A Hischa; K Tatsch; H J Reulen
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  MMP-2 downregulation mediates differential regulation of cell death via ErbB-2 in glioma xenografts.

Authors:  Christopher S Gondi; Dzung H Dinh; Jeffrey D Klopfenstein; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2009-08       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.